Purchase Order 75N95C25P00106
Award Date
9/18/25
Potential Completion Date
9/17/26
Potential Value
$13K
Federal Agency
National Center for Advancing Translational Sciences
Awardee
Dexorgen Inc.
Ultimate Awardee
Not listed
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $29,400 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Dexorgen Inc., doing business as Codex Biosolutions Inc. Codex Biosolutions is a minority-owned, small disadvantaged business that specializes in advanced biotechnological research, particularly in cell line development, genetic engineering, and translational science support. The contract,...
This federal contract award to Dexorgen Inc., doing business as Codex Biosolutions Inc., was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH). The $24,000.00 firm-fixed price purchase order is for the "GENERATION AND CHARACTERIZATION IPSC DERIVED BRAIN ORGANOIDS FROM BAIN TYPE X-LINKED MENTAL RETARDATION SYNDROME (MRXSB)". Codex Biosolutions is a minority-owned small disadvantaged business that...
This $18,000 firm fixed price purchase order was awarded by the National Institutes of Health's National Institute on Drug Abuse to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. Codex Biosolutions provides cell-based assay products and services to support research and development activities for government agencies, pharmaceutical companies, and other institutes. Under this contract, Codex is tasked with delivering specialized cell lines,...
This contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. The $18,060 firm fixed-price purchase order is for screening services to identify small molecule antagonists of the GPR17 receptor, which is involved in various diseases. Codex Biosolutions specializes in cell-based assays and has received numerous NIH contracts for research and...
This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. The $15,100 firm fixed-price purchase order contract is for Codex Biosolutions to provide research and development services, including generating custom cell lines and supplying pseudovirus particles and stable cell lines expressing SARS-CoV-2 variants to...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $25,000 firm fixed price purchase order to Codex Biosolutions Inc., located in Gaithersburg, Maryland. Codex Biosolutions will provide research and development services under the award, which runs from September 1, 2023 through August 31, 2024. As the prime contractor, Codex Biosolutions will leverage its expertise to support the National Center for...
Codex Biosolutions Inc. Research and Development Division, doing business as Codex Biosolutions Inc., has been awarded a $18,400 firm fixed-price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide cell line generation services. The contract has a period of performance of September 1, 2023 through August 31, 2024 and will be performed in Gaithersburg, Maryland. No set-aside designation or subcontractors were indicated. The award...
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $35,025 firm fixed price purchase order to Codex Biosolutions Inc. under a non-competitive solicitation. Codex will generate a stable P/Q type calcium channel CaV2.1 cell line by cloning specified channel proteins into HEK293 cells and introducing an additional channel to control calcium flux, as described in the attached statement of work. The one-year contract has a period of performance from...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Codex Biosolutions Inc., a minority-owned small disadvantaged business, to identify cellular factors that impact the production of a full-length HIV-1 envelope trimer without altering its native antigenic properties. The $599,424.00 firm-fixed-price contract is funded through the Small Business Innovation Research (SBIR) program and...
Codex Biosolutions Inc. has been awarded a firm fixed price purchase order valued at $22,620 by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health within the Department of Health and Human Services, to deliver an EXPI293 stable cell line overexpressing HTLV envelope protein in support of NIAID's efforts to develop treatments and preventions for infectious diseases. The research and development will be conducted by Codex...